Publisher
Springer Berlin Heidelberg
Reference266 articles.
1. Aber CP, Bass NM, Berry CL, Carson PHM, Dobbs RJ, Fox KM, Hamblin JJ, Haydu SP, Howitt G, MacIver JE, Portal RW, Raftery EB, Rousell RH, Stock JPP (1976) Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. Br Med J 2:1100–1104
2. Agostoni A, Gardinali M, Frangi D, Cafaro C, Conciato L, Sponzilli C, Salvioni A, Cugno M, Cicardi M (1994) Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator. Circulation 90:2666–2670
3. AIMS Trial Study Group (1988) Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1:545–549
4. AIMS Trial Study Group (1990) Long-term effects of intravenous anistreplase in acute myocardial infarction. Lancet 335:427–431
5. Amery A, Roeber G, Vermeulen HJ, Verstraete M (1969) Single-blind randomized multicentre trial comparing heparin and streptokinase treatment in recent myocardial infarction. Acta Med Scand 505 [Suppl]:1–35